Trials / Terminated
TerminatedNCT02162628
Exair® Versus Native Tissue Repair for Prolapse
Exair® Prolapse Repair System Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Exair 522 Study
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Coloplast A/S · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare safety and effectiveness of the Exair Prolapse Repair System for treatment of pelvic organ prolapse to traditional native tissue repair through 36 months of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Exair Prolapse Repair System | |
| PROCEDURE | Total Native Tissue Repair |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-06-13
- Last updated
- 2015-12-14
Locations
14 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02162628. Inclusion in this directory is not an endorsement.